COOT Stock Price Chart
Daily OHLCV with technical indicators — pan, zoom, and customize your view
04
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance
Revenue, net income, margins and EPS trends
06
Revenue$42M2023-06-30 → 2025-06-30
EPS$-0.062023-06-30 → 2025-06-30
Free Cash Flow$-413.7K2025-06-30 → 2025-06-30
Net margin-66.0%2025-06-30 → 2025-06-30
Valuation & Ratios07–12
Valuation
P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
COOT
5Y avg
Peer Median
Verdict
P/E (TTM)
-0.4
·
·
·
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability
Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
COOT
5Y avg
Peer Median
Verdict
Gross Margin (TTM)
9.5%
·
·
·
Operating Margin (TTM)
-0.23%
·
·
·
EBITDA Margin
0.00%
·
·
·
Pretax Margin (TTM)
-65.7%
·
·
·
Net Profit Margin (TTM)
-66.0%
·
·
·
ROA
-4.0%
·
·
·
ROE
-120.8%
·
·
·
ROIC
-0.01%
·
·
·
Financial Health
Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
COOT
5Y avg
Peer Median
Verdict
Current Ratio (MRQ)
0.6
·
·
·
Quick Ratio
0.3
·
·
·
Interest Coverage
-0.0
·
·
·
Growth
Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
COOT
5Y avg
Peer Median
Verdict
Revenue YoY
16.1%
·
·
·
Per Share Metrics
EPS, book value per share, cash flow per share, dividend per share
Metric
5Y trend
COOT
5Y avg
Peer Median
Verdict
EPS (Diluted)
$-0.065Y avg ≈$-0.34
≈$-0.34
·
·
Revenue / Share
$1.76
·
·
·
Cash Flow / Share
$0.04
·
·
·
Capital Efficiency
Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
COOT
5Y avg
Peer Median
Verdict
Asset Turnover
1.3
·
·
·
Inventory Turnover
6.3
·
·
·
Receivables Turnover
8.5
·
·
·
Revenue / Employee
≈$2.6M
·
·
·
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History
EPS actual vs estimate, surprise %, beat rate, next earnings date
14
Next ReportOct 21, 2026
Full Fundamentals
All metrics by year — income statement, balance sheet, cash flow
15
Income Statement14
Metric
Trend
2025
2024
2023
Revenue
$42M
$34M
$29M
Cost of Revenue
$38M
$28M
$24M
Gross Profit
$3M
$6M
$5M
SG&A Expense
$372.7K
$412.5K
·
Operating Income
$-323
$3M
$3M
Interest Expense
$991.6K
·
·
Pretax Income
$-1M
$-21M
$2M
Income Tax
$49.1K
$313.4K
$109.9K
Net Income
$-1M
$-22M
$1M
EPS (Basic)
$-0.06
$-1.07
$0.10
EPS (Diluted)
$-0.06
$-1.07
$0.10
Shares (Basic)
23,640,568
19,900,741
18,646,643
Shares (Diluted)
23,640,568
19,900,741
18,646,643
EBITDA
$-323
·
·
Balance Sheet11
Metric
Trend
2025
2024
2023
Cash & Equivalents
$2M
$514.1K
$121.3K
Receivables
$5M
$4M
$4M
Inventory
$6M
$6M
$1M
Current Assets
$15M
$11M
$10M
PP&E (Net)
$16M
$15M
$11M
Intangibles
$3M
$3M
$3M
Total Assets
$34M
$30M
$24M
Current Liabilities
$28M
$18M
$10M
Total Liabilities
$30M
$29M
$16M
Retained Earnings
$-19M
$-18M
$4M
Stockholders' Equity
$3M
$-882.0K
$6M
Cash Flow6
Metric
Trend
2025
2024
2023
Operating Cash Flow
$966.5K
$-2M
$689.8K
CapEx
$1M
$4M
$3M
Investing Cash Flow
$-1M
$-4M
$-3M
Financing Cash Flow
$2M
$7M
$2M
Free Cash Flow
$-413.7K
·
·
Levered FCF
$-1M
·
·
Profitability8
Metric
Trend
2025
2024
2023
Gross Margin
8.3%
·
·
Operating Margin
0.00%
·
·
Net Margin
-3.1%
·
·
Pretax Margin
-3.4%
·
·
EBITDA Margin
0.00%
·
·
ROA
-4.0%
·
·
ROE
-120.8%
·
·
ROIC
-0.01%
·
·
Liquidity & Solvency3
Metric
Trend
2025
2024
2023
Current Ratio
0.5
·
·
Quick Ratio
0.3
·
·
Interest Coverage
-0.0
·
·
Efficiency3
Metric
Trend
2025
2024
2023
Asset Turnover
1.3
·
·
Inventory Turnover
6.3
·
·
Receivables Turnover
8.5
·
·
Per Share3
Metric
Trend
2025
2024
2023
Revenue / Share
$1.76
·
·
Cash Flow / Share
$0.04
·
·
EPS (TTM)
$-0.06
·
·
Growth Rates1
Metric
Trend
2025
2024
2023
Revenue YoY
·
16.1%
·
Valuation (TTM)4
Metric
Trend
2025
2024
2023
Revenue TTM
$42M
·
·
Net Income TTM
$-1M
·
·
P/E
-12.5
·
·
Earnings Yield
-8.0%
·
·
Income Statement14
Metric
Trend
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Revenue
$9M
$10M
$10M
$8M
$6M
$10M
$10M
Cost of Revenue
$9M
$9M
$9M
$7M
$6M
$8M
$7M
Gross Profit
$565.6K
$1M
$830.4K
$998.0K
$603.4K
$2M
$2M
SG&A Expense
$70.0K
$85.2K
$199.3K
$142.3K
$15.0K
$186.3K
$68.9K
Operating Income
$-110.3K
$9.5K
$-167.0K
$180.0K
$203.4K
$1M
$2M
Interest Expense
$471.2K
$-341.5K
$479.3K
$451.0K
$162.3K
·
$109.2K
Pretax Income
$-581.5K
$-320.3K
$-646.3K
$-23M
$41.2K
$970.4K
$1M
Income Tax
$49.1K
·
·
·
·
·
·
Net Income
$-559.8K
$-328.3K
$-613.7K
$-24M
$26.3K
$735.7K
$1M
EPS (Basic)
$-0.03
$-0.01
$-0.03
$-1.19
$0.00
$0.04
$0.08
EPS (Diluted)
$-0.03
$-0.01
$-0.03
$-1.19
$0.00
$0.04
$0.08
Shares (Basic)
23,224,102
23,224,102
23,224,102
·
18,646,643
18,646,643
18,646,643
Shares (Diluted)
23,224,102
23,224,102
23,224,102
·
18,646,643
18,646,643
18,646,643
EBITDA
$-110.3K
$9.5K
$-167.0K
·
·
·
·
Balance Sheet11
Metric
Trend
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Cash & Equivalents
$1M
$1M
$2M
$514.1K
·
·
·
Receivables
$6M
$7M
$5M
$4M
·
·
·
Inventory
$4M
$5M
$7M
$6M
·
·
·
Current Assets
$12M
$14M
$14M
$11M
·
·
·
PP&E (Net)
$16M
$16M
$16M
$15M
·
·
·
Intangibles
$3M
$3M
$3M
$3M
·
·
·
Total Assets
$31M
$33M
$33M
$30M
·
·
·
Current Liabilities
$22M
$22M
$28M
$18M
·
·
·
Total Liabilities
$32M
$33M
$33M
$29M
·
·
·
Retained Earnings
$-19M
$-19M
$-19M
$-18M
·
·
·
Stockholders' Equity
$-3M
$-2M
$-1M
$-882.0K
·
·
·
Cash Flow5
Metric
Trend
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Operating Cash Flow
$526.0K
$-3M
$588.3K
$-3M
$3M
$-50.2K
$-2M
CapEx
$96.8K
$227.7K
$577.4K
$673.6K
$2M
$1M
$640.9K
Investing Cash Flow
$-96.8K
$-227.7K
$-577.4K
$-673.6K
$-2M
$-1M
$-640.9K
Financing Cash Flow
$-431.7K
$3M
$2M
$4M
$-743.7K
$1M
$2M
Free Cash Flow
·
·
$11.0K
·
·
·
·
Profitability8
Metric
Trend
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Gross Margin
6.0%
11.6%
8.0%
·
·
·
·
Operating Margin
-1.2%
0.09%
-1.6%
·
·
·
·
Net Margin
-5.9%
-3.2%
-5.9%
·
·
·
·
Pretax Margin
-6.2%
-3.1%
-6.3%
·
·
·
·
EBITDA Margin
-1.2%
0.09%
-1.6%
·
·
·
·
ROA
-3.6%
-2.0%
-3.7%
·
·
·
·
ROE
41.4%
36.0%
82.1%
·
·
·
·
ROIC
4.4%
·
·
·
·
·
·
Liquidity & Solvency3
Metric
Trend
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Current Ratio
0.6
0.6
0.5
·
·
·
·
Quick Ratio
0.3
0.4
0.3
·
·
·
·
Interest Coverage
-0.2
·
-0.3
·
·
·
·
Efficiency3
Metric
Trend
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Asset Turnover
0.6
0.6
0.6
·
·
·
·
Inventory Turnover
4.2
3.8
2.9
·
·
·
·
Receivables Turnover
3.3
3.2
4.1
·
·
·
·
Per Share3
Metric
Trend
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Revenue / Share
$0.41
$0.45
$0.44
·
·
·
·
Cash Flow / Share
·
·
$0.03
·
·
·
·
EPS (TTM)
$-1.26
$-1.23
$-1.18
·
·
·
·
Valuation (TTM)4
Metric
Trend
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Revenue TTM
$38M
$35M
$34M
·
·
·
·
Net Income TTM
$-25M
$-24M
$-23M
·
·
·
·
P/E
-1.0
-1.0
-0.7
·
·
·
·
Earnings Yield
-98.4%
-103.4%
-134.2%
·
·
·
·
Most recent period on the left · null values shown as ·
Financial Statements
Income statement, balance sheet, cash flow — annual, last 5 years
16
Metric
2025-06-30
2024-06-30
2023-06-30
Revenue
$42M
$34M
$29M
Gross Margin %
8.3%
·
·
Operating Margin %
0.00%
·
·
Net Income
$-1M
$-22M
$1M
Diluted EPS
$-0.06
$-1.07
$0.10
Metric
2025-06-30
2024-06-30
2023-06-30
Current Ratio
0.5
·
·
Quick Ratio
0.3
·
·
Metric
2025-06-30
2024-06-30
2023-06-30
Free Cash Flow
$-413.7K
·
·
Institutional owners (13F)
9 filers
· $133K total
· As of June 30, 2026
17
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders9
Value held$133K
New positions5
Exited positions3
Institutional activity — Q2 2026 vs prior quarter
New positions
Exited positions
Increased
Decreased
Net shares change
5 (+1 vs prior Q)
3 (-3 vs prior Q)
0 (-1 vs prior Q)
1 (0 vs prior Q)
+59K
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.